| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Anteris Technologies Global Corp is a structural heart company focused on advancing cardiac care through science-driven innovations aimed at restoring heart valve patients to healthy function. Its key product, the DurAVR Transcatheter Heart Valve...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Anteris Technologies Glb (NASDAQ:AVR) through any online brokerage.
Other companies in Anteris Technologies Glb’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Medtronic PLC (NYSE:MDT), Stryker Corp (NYSE:SYK) and Boston Scientific Corp (NYSE:BSX).
Anteris Technologies Glb has a consensus price target of $14.17.
The stock price for Anteris Technologies Glb (NASDAQ: AVR) is $6.05 last updated October 16, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Anteris Technologies Glb.
Anteris Technologies Glb does not have any upcoming earnings scheduled.
There is no upcoming split for Anteris Technologies Glb.
Anteris Technologies Glb is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
